| Literature DB >> 20534741 |
Jason J Corneveaux1, Amanda J Myers, April N Allen, Jeremy J Pruzin, Manuel Ramirez, Anzhelika Engel, Michael A Nalls, Kewei Chen, Wendy Lee, Kendria Chewning, Stephen E Villa, Hunsar B Meechoovet, Jill D Gerber, Danielle Frost, Hollie L Benson, Sean O'Reilly, Lori B Chibnik, Joshua M Shulman, Andrew B Singleton, David W Craig, Kendall R Van Keuren-Jensen, Travis Dunckley, David A Bennett, Philip L De Jager, Christopher Heward, John Hardy, Eric M Reiman, Matthew J Huentelman.
Abstract
In this study, we assess 34 of the most replicated genetic associations for Alzheimer's disease (AD) using data generated on Affymetrix SNP 6.0 arrays and imputed at over 5.7 million markers from a unique cohort of over 1600 neuropathologically defined AD cases and controls (1019 cases and 591 controls). Testing the top genes from the AlzGene meta-analysis, we confirm the well-known association with APOE single nucleotide polymorphisms (SNPs), the CLU, PICALM and CR1 SNPs recently implicated in unusually large data sets, and previously implicated CST3 and ACE SNPs. In the cases of CLU, PICALM and CR1, as well as in APOE, the odds ratios we find are slightly larger than those previously reported in clinical samples, consistent with what we believe to be more accurate classification of disease in the clinically characterized and neuropathologically confirmed AD cases and controls.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20534741 PMCID： PMC2908469 DOI： 10.1093/hmg/ddq221
Source DB: PubMed Journal: Hum Mol Genet ISSN： 0964-6906 Impact factor: 6.150